S&P 500 · Health Care · USD · FY end 2025-12-31
Abbott Laboratories (ABT) financials — revenue, earnings, margins, balance sheet, cash flow and dividends. 10-year history sourced from SEC filings.
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| FY2025 | 44.33B | 6.52B | 3.72 | 7.39B |
| FY2024 | 41.95B | 13.40B | 7.64 | 6.35B |
| FY2023 | 40.11B | 5.72B | 3.26 | 5.06B |
| FY2022 | 43.65B | 6.93B | 3.91 | 7.80B |
| FY2021 | 43.08B | 7.07B | 3.94 | 8.65B |